← Leaderboards
Thomas Larocca
University Of Colorado
$3,234,486
Attributed
$3,445,595
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $886.1K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,445,595 · 6
By mechanism
R21$1,584,804 · 3
R01$1,491,870 · 1
R03$304,000 · 1
F31$64,921 · 1
Top collaborators
- Daniel Lark2 shared
Most similar at University Of Colorado
Same institution · by research overlap
- Douglas R Seals$39,040,406
- L. Cinnamon Bidwell$10,727,430
- Charles A Hoeffer$5,996,706
- Laura K Fonken$5,186,756
- William M Sheeran$163,635
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAgingLinkInflammationAge RelatedNeurodegenerative DisordersInsightData SetFutureNeuroinflammationBrainImpairmentTau ProteinsS DiseaseEventTranscriptome SequencingPathologySignal TransductionGenesAging BrainGenetic TranscriptionS Disease RiskRepetitive SequenceCognitive Function
Grant awards (15)
Age-related repetitive element dysregulation, neuroinflammation and Alzheimer's disease$360,157
R01 · FY2025 · AG · contact PI
Targeting age-related endosome dysfunction to treat cognitive decline and Alzheimer's disease$191,875
R21 · FY2025 · AG
A novel approach for targeting neuroinflammation in brain aging and Alzheimer's disease$115,500
R21 · FY2025 · AG · contact PI
Age-related repetitive element dysregulation, neuroinflammation and Alzheimer's disease$373,775
R01 · FY2024 · AG · contact PI
A novel approach for targeting neuroinflammation in brain aging and Alzheimer's disease$281,962
R21 · FY2024 · AG · contact PI
Targeting age-related endosome dysfunction to treat cognitive decline and Alzheimer's disease$230,344
R21 · FY2024 · AG
Age-related repetitive element dysregulation, neuroinflammation and Alzheimer's disease$381,880
R01 · FY2023 · AG · contact PI
Age-related repetitive element dysregulation, neuroinflammation and Alzheimer's disease$376,058
R01 · FY2022 · AG · contact PI
Role of age-dependent repetitive element transcript dysregulation in Alzheimers disease$152,000
R03 · FY2022 · AG · contact PI
Role of age-dependent repetitive element transcript dysregulation in Alzheimers disease$152,000
R03 · FY2021 · AG · contact PI
Inclusive Transcriptomics to Uncover Molecular Mechanisms of Alzheimer's Disease$334,101
R21 · FY2020 · AG · contact PI
Inclusive Transcriptomics to Uncover Molecular Mechanisms Underlying Healthspan$158,623
R21 · FY2020 · AG · contact PI
Inclusive Transcriptomics to Uncover Molecular Mechanisms Underlying Healthspan$272,399
R21 · FY2019 · AG · contact PI
Role of Autophagy in Vascular Endothelial Dysfunction with Aging$29,739
F31 · FY2012 · AG · contact PI
Role of Autophagy in Vascular Endothelial Dysfunction with Aging$35,182
F31 · FY2011 · AG · contact PI